← Back to Search

Behavioural Intervention

Peer Health Coaching for HIV (ACCESS Trial)

N/A
Waitlist Available
Led By Ann-Margaret Navarra, PhD, CPNP-PC
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18-29 years
HIV seropositive status (perinatally and behaviorally infected youth)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks, 24 weeks
Awards & highlights

ACCESS Trial Summary

This trial is testing whether connecting with a trained peer health coach via videoconferencing can help improve ART adherence and HIV-viral load in Black and Hispanic HIV-infected adolescents and young adults, compared to those who only have access to a web-based HIV ART adherence education.

Who is the study for?
This trial is for Black and Hispanic HIV+ young adults, ages 18-29, who are on antiretroviral treatment but have a detectable viral load over 200 copies/ml. They must speak English and be able to participate in videoconferencing without neuro-cognitive deficits.Check my eligibility
What is being tested?
The ACCESS II study tests if an mHealth intervention with peer health coaches improves ART adherence and lowers HIV-viral load. Participants will either receive weekly live coaching sessions or access web-based education on ART adherence.See study design
What are the potential side effects?
Since the interventions involve counseling and educational support rather than medication, no direct medical side effects are expected from participating in this trial.

ACCESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 29 years old.
Select...
I am HIV positive.
Select...
I am currently on medication for HIV.

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence self-efficacy
Change in serum HIV RNA quantitative viral load
Self-reported ART adherence
Secondary outcome measures
Change in Anxiety
Change in Depression
Change in HIV stigma
+5 more

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HIV-infected youth: InterventionExperimental Treatment1 Intervention
Sample population of perinatally and behaviorally, HIV-infected youth (ages 18-29 years). Characteristics of the target study population include ethnic minority, Black and Hispanic HIV+AYA; both males and females are eligible for participation.
Group II: HIV-infected youth: controlActive Control1 Intervention
Sample population of perinatally and behaviorally, HIV-infected youth (ages 18-29 years). Characteristics of the target study population include ethnic minority, Black and Hispanic HIV+AYA; both males and females are eligible for participation.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,753 Total Patients Enrolled
Jacobi Medical CenterOTHER
22 Previous Clinical Trials
4,291 Total Patients Enrolled
Ann-Margaret Navarra, PhD, CPNP-PCPrincipal InvestigatorNYU Meyers College of Nursing

Media Library

ACCESS II mHealth Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04499781 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: HIV-infected youth: Intervention, HIV-infected youth: control
Human Immunodeficiency Virus Infection Clinical Trial 2023: ACCESS II mHealth Intervention Highlights & Side Effects. Trial Name: NCT04499781 — N/A
ACCESS II mHealth Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04499781 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are enrolled in this experiment?

"Affirmative. The information on clinicaltrials.gov verifies that this research project is actively recruiting participants, which began being posted on February 14th 2022 and was last updated in March 24th 2022. 120 individuals are required to be enlisted from 2 different locales."

Answered by AI

Is this medical investigation open to those elderly sixty and over?

"This trial is exclusively available to those aged 18-29. There are also 108 clinical trials for minors and 352 medical studies targeting the elderly cohort."

Answered by AI

Does this research still need participants?

"According to the current information on clinicaltrials.gov, this medical trial is recruiting participants with its first posting made on February 14th 2022 and most recent update taking place on March 24th 2022."

Answered by AI

Could you elucidate the key aims of this research endeavor?

"This 3-day clinical trial aims to assess Adherence self-efficacy. Secondary objectives include Client Satisfaction and Ease of Use of the web platform, Change in Knowledge about ART, and Change in Social support and Isolation. To measure these goals, a modified Client Satisfaction Questionnaire, Perceived Ease of Use Scale, HIV Treatment Knowledge Scale (scores range from 0-21), and ATN iTech short measure with scores ranging between 25 - 125 will be used."

Answered by AI

Am I a qualified participant for this research endeavor?

"120 participants aged between 18 and 29 with HIV are welcome to submit an application for this trial. Notably, the following conditions must be met: No cognitive problems that could interfere with videoconferencing or study completion; Ages 18-29 years old."

Answered by AI
~2 spots leftby May 2024